NCT01578707 · Interventional trial
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Overall registry status Completed
Phase 3
Conditions Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Delaware Valley sites
- Site # 402 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory